166 related articles for article (PubMed ID: 3027278)
1. A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems.
Millan MJ; Członkowski A; Pilcher CW; Almeida OF; Millan MH; Colpaert FC; Herz A
J Neurosci; 1987 Jan; 7(1):77-87. PubMed ID: 3027278
[TBL] [Abstract][Full Text] [Related]
2. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.
Millan MJ; Członkowski A; Morris B; Stein C; Arendt R; Huber A; Höllt V; Herz A
Pain; 1988 Dec; 35(3):299-312. PubMed ID: 2906425
[TBL] [Abstract][Full Text] [Related]
3. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
Millan MJ; Colpaert FC
Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
[TBL] [Abstract][Full Text] [Related]
4. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
5. Functional response of multiple opioid systems to chronic arthritic pain in the rat.
Millan MJ; Millan MH; Członkowski A; Pilcher CW; Höllt V; Colpaert FC; Herz A
Ann N Y Acad Sci; 1986; 467():182-93. PubMed ID: 2873784
[No Abstract] [Full Text] [Related]
6. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
7. A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis.
Millan MJ; Millan MH; Członkowski A; Höllt V; Pilcher CW; Herz A; Colpaert FC
J Neurosci; 1986 Apr; 6(4):899-906. PubMed ID: 2871141
[TBL] [Abstract][Full Text] [Related]
8. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord dynorphin may modulate nociception via a kappa-opioid receptor in chronic arthritic rats.
Millan MJ; Millan MH; Pilcher CW; Członkowski A; Herz A; Colpaert FC
Brain Res; 1985 Aug; 340(1):156-9. PubMed ID: 2862957
[TBL] [Abstract][Full Text] [Related]
10. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
[TBL] [Abstract][Full Text] [Related]
11. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
Herrero JF; Headley PM
Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
[TBL] [Abstract][Full Text] [Related]
12. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
13. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
14. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
[TBL] [Abstract][Full Text] [Related]
15. A model of chronic pain in the rat: high-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal grey.
Millan MJ; Morris BJ; Colpaert FC; Herz A
Brain Res; 1987 Jul; 416(2):349-53. PubMed ID: 3040180
[TBL] [Abstract][Full Text] [Related]
16. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
17. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.
Bero LA; Lurie SN; Kuhn CM
Brain Res; 1987 Dec; 465(1-2):189-96. PubMed ID: 2894234
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
Knox RJ; Dickenson AH
Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of specific delta and kappa opioid receptor antagonists on the bidirectional dose-dependent effect of systemic naloxone in arthritic rats, an experimental model of persistent pain.
Cattaneo I; Kayser V; Guilbaud G
Brain Res; 1993 Oct; 623(2):201-7. PubMed ID: 8221101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
